Tokyo Tape
Sign in
← Oncolys BioPharma

Annual report

4588.TEDINET S100XTMG
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 78
MetricValuePeriodScopeSource row
Revenue¥29m2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥31m2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥63m2023-01-01 → 2023-12-31vStandaloneNet sales (5-year summary)
Revenue¥976m2022-01-01 → 2022-12-31vStandaloneNet sales (5-year summary)
Revenue¥642m2021-01-01 → 2021-12-31vStandaloneNet sales (5-year summary)
Operating income−¥2.0bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income−¥2.1bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income−¥1.7bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.2bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.5bn2021-01-01 → 2021-12-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥2.1bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥1.7bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income−¥2.1bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income−¥1.7bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥1.9bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income−¥1.6bn2021-01-01 → 2021-12-31vStandaloneNet income loss (5-year summary)
Total assets¥4.6bnat 2025-12-31StandaloneAssets
Total assets¥3.2bnat 2024-12-31StandaloneAssets
Total assets¥2.0bnat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥2.7bnat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥4.3bnat 2021-12-31vStandaloneTotal assets (5-year summary)
Total liabilities¥556mat 2025-12-31StandaloneLiabilities
Total liabilities¥447mat 2024-12-31StandaloneLiabilities
Net assets / equity¥4.0bnat 2025-12-31StandaloneNet assets
Net assets / equity¥2.8bnat 2024-12-31StandaloneNet assets
Net assets / equity¥1.5bnat 2023-12-31vStandaloneNet assets
Net assets / equity¥2.2bnat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥3.6bnat 2021-12-31vStandaloneNet assets (5-year summary)
Cash and deposits¥3.7bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥2.4bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥3.4bnat 2025-12-31StandaloneCash and cash equivalents
Cash & equivalents¥2.2bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.3bnat 2023-12-31vStandaloneCash and cash equivalents
Cash & equivalents¥1.5bnat 2022-12-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥3.2bnat 2021-12-31vStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.9bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥2.0bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥1.3bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.7bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥8m2025-01-01 → 2025-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥20m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥942,0002021-01-01 → 2021-12-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.2bn2025-01-01 → 2025-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2023-01-01 → 2023-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥114m2022-01-01 → 2022-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.1bn2021-01-01 → 2021-12-31vStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-802025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-77.172024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-108.922023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.312022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-95.52021-01-01 → 2021-12-31vStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥136.38at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥110.4at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥74.35at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥124.2at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥206.86at 2021-12-31vStandaloneNet assets per share (5-year summary)
Equity ratio87.6%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio85.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio71.5%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio81.2%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.6%at 2021-12-31vStandaloneEquity to asset ratio (5-year summary)
Shares issued29,291,600at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued24,961,600at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,717,100at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued17,405,200at 2021-12-31vStandaloneTotal number of issued shares (5-year summary)
Employees38at 2025-12-31StandaloneNumber of employees
Employees35at 2024-12-31StandaloneNumber of employees
Employees34at 2023-12-31vStandaloneNumber of employees
Employees33at 2022-12-31vStandaloneNumber of employees
Employees33at 2021-12-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 834
ItemContextValueUnit
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember7680000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember7680000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember2752209000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember3999969000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember3198858000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember4555879000JPY
Net salesPrior1YearDuration_NonConsolidatedMember31384000JPY
Net salesCurrentYearDuration_NonConsolidatedMember28546000JPY
Cost of service cos exp oaPrior1YearDuration_NonConsolidatedMember－JPY
Cost of service cos exp oaCurrentYearDuration_NonConsolidatedMember－JPY
Beginning finished goods cosPrior1YearDuration_NonConsolidatedMember－JPY
Beginning finished goods cosCurrentYearDuration_NonConsolidatedMember－JPY
Total beginning finished goods and cost of products manufactured for the periodPrior1YearDuration_NonConsolidatedMember－JPY
Total beginning finished goods and cost of products manufactured for the periodCurrentYearDuration_NonConsolidatedMember－JPY
Finished goods transfer to other account cosPrior1YearDuration_NonConsolidatedMember－JPY
Finished goods transfer to other account cosCurrentYearDuration_NonConsolidatedMember－JPY
Ending finished goods cosPrior1YearDuration_NonConsolidatedMember－JPY
Ending finished goods cosCurrentYearDuration_NonConsolidatedMember－JPY
Gross profitPrior1YearDuration_NonConsolidatedMember31384000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember28546000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1712787000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember2052614000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1681403000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-2024068000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember2145000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember3949000JPY
Dividends income noiPrior1YearDuration_NonConsolidatedMember5000JPY
Dividends income noiCurrentYearDuration_NonConsolidatedMember3000JPY
Foreign exchange gains noiPrior1YearDuration_NonConsolidatedMember43775000JPY
Foreign exchange gains noiCurrentYearDuration_NonConsolidatedMember－JPY
Other noiPrior1YearDuration_NonConsolidatedMember40000JPY
Other noiCurrentYearDuration_NonConsolidatedMember90000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember45966000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember4042000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember4597000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember5234000JPY
Amortization of restricted stock remuneration noePrior1YearDuration_NonConsolidatedMember6205000JPY
Amortization of restricted stock remuneration noeCurrentYearDuration_NonConsolidatedMember6098000JPY
Share acquisition rights issuance costs noePrior1YearDuration_NonConsolidatedMember7202000JPY
Share acquisition rights issuance costs noeCurrentYearDuration_NonConsolidatedMember7177000JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember10394000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember9222000JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember－JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember3485000JPY
Other noePrior1YearDuration_NonConsolidatedMember73000JPY
Other noeCurrentYearDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YearDuration_NonConsolidatedMember28473000JPY
Non operating expensesCurrentYearDuration_NonConsolidatedMember31218000JPY
Ordinary incomePrior1YearDuration_NonConsolidatedMember-1663911000JPY
Ordinary incomeCurrentYearDuration_NonConsolidatedMember-2051244000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass